IL126623A0 - Pharmaceutical compositions and kits for dhea combined therapy - Google Patents

Pharmaceutical compositions and kits for dhea combined therapy

Info

Publication number
IL126623A0
IL126623A0 IL12662397A IL12662397A IL126623A0 IL 126623 A0 IL126623 A0 IL 126623A0 IL 12662397 A IL12662397 A IL 12662397A IL 12662397 A IL12662397 A IL 12662397A IL 126623 A0 IL126623 A0 IL 126623A0
Authority
IL
Israel
Prior art keywords
kits
pharmaceutical compositions
combined therapy
dhea
dhea combined
Prior art date
Application number
IL12662397A
Other languages
English (en)
Original Assignee
Prendergast Patrick T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prendergast Patrick T filed Critical Prendergast Patrick T
Publication of IL126623A0 publication Critical patent/IL126623A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL12662397A 1996-04-17 1997-04-17 Pharmaceutical compositions and kits for dhea combined therapy IL126623A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1569596P 1996-04-17 1996-04-17
PCT/IB1997/000414 WO1997038695A1 (en) 1996-04-17 1997-04-17 Dhea combination therapy

Publications (1)

Publication Number Publication Date
IL126623A0 true IL126623A0 (en) 1999-08-17

Family

ID=21773003

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12662397A IL126623A0 (en) 1996-04-17 1997-04-17 Pharmaceutical compositions and kits for dhea combined therapy

Country Status (9)

Country Link
EP (1) EP0901375A1 (xx)
JP (1) JP2000508654A (xx)
KR (1) KR20000005539A (xx)
CN (1) CN1216470A (xx)
AU (1) AU734807B2 (xx)
CA (1) CA2251733A1 (xx)
IL (1) IL126623A0 (xx)
NO (1) NO984851L (xx)
WO (1) WO1997038695A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915623A (pt) * 1998-11-24 2001-08-14 Hollis Eden Pharmaceuticals Uso de compostos de 17-cetoesteróides e derivados, metabolitos e precursores dos mesmos no tratamento de malária e no tratamento de tripanossomìase africana e americana
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
AU775614B2 (en) * 1998-11-24 2004-08-05 Harbor Biosciences, Inc. Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other togaviruses
AU1923500A (en) * 1998-11-27 2000-06-19 Hollis-Eden Pharmaceuticals, Inc. Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in treatment of toxoplasmosis and in the treatment of cryptosporidiosis
WO2014166501A2 (en) * 2013-04-10 2014-10-16 Skau Aps Use of immune suppressive peptides as adjuvants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815472A1 (de) * 1988-05-06 1989-11-16 Centre Regional De Transfusion Monoklonaler antikoerper und seine verwendung
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
IL106725A (en) * 1992-08-20 2000-12-06 Schering Plough Corp Pharmaceutical composition for treating inflammatory bowel disease comprising IL-10
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
JP2000508654A (ja) 2000-07-11
CN1216470A (zh) 1999-05-12
CA2251733A1 (en) 1997-10-23
AU2574197A (en) 1997-11-07
EP0901375A1 (en) 1999-03-17
NO984851L (no) 1998-12-17
AU734807B2 (en) 2001-06-21
KR20000005539A (ko) 2000-01-25
NO984851D0 (no) 1998-10-16
WO1997038695A1 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
HK1112180A1 (en) Pharmaceutical use and compositions involving isoflavones
IL136972A0 (en) Novel anti-estrogenic steroids and associated pharmaceutical compositions and methods of use
AU3890297A (en) Herbal formulation and therapeutic uses therefor
EP0943327A4 (en) DRUG
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
IL138888A0 (en) Pharmaceutical composition and combination preparation for immunosuppressive therapy
HU9603487D0 (en) Triterpene derivative and medicinal composition
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
EP0889051A4 (en) TRITERPEN DERIVATIVES AND MEDICINES FOR LIVER DISEASES
AU5333298A (en) Compositions and methods for tumour therapy
IL126623A0 (en) Pharmaceutical compositions and kits for dhea combined therapy
ZA9710934B (en) Compositions and methods for administering pneumococal dna
EP0987942A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF USE
GB9606579D0 (en) Pharmaceutical composition and methods for the manufacture thereof
GB9623962D0 (en) Pharmaceutical composition
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them
AUPO982097A0 (en) Methods and compositions for use therein
AU8038298A (en) Triterpene derivatives and medicinal composition
HUP9901968A3 (en) 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them
AU3423397A (en) Therapeutic methods and compositions for use therein
AU1801297A (en) Spiro-ketal derivatives and their use as therapeutic agents
GB9603471D0 (en) Therapeutic methods and compositions for use therein
GB9620592D0 (en) Pharmaceutical compositions and their use